198 related articles for article (PubMed ID: 17585009)
1. Pediatric quality of life in transitioning to the insulin pump: does prior regimen make a difference?
Cogen FR; Henderson C; Hansen JA; Streisand R
Clin Pediatr (Phila); 2007 Nov; 46(9):777-9. PubMed ID: 17585009
[TBL] [Abstract][Full Text] [Related]
2. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
[TBL] [Abstract][Full Text] [Related]
3. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections.
; Nicolucci A; Maione A; Franciosi M; Amoretti R; Busetto E; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Ponzi P; Vitacolonna E
Diabet Med; 2008 Feb; 25(2):213-20. PubMed ID: 18201210
[TBL] [Abstract][Full Text] [Related]
4. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
5. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus.
Opipari-Arrigan L; Fredericks EM; Burkhart N; Dale L; Hodge M; Foster C
Pediatr Diabetes; 2007 Dec; 8(6):377-83. PubMed ID: 18036064
[TBL] [Abstract][Full Text] [Related]
6. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
7. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
Eugster EA; Francis G;
Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
[TBL] [Abstract][Full Text] [Related]
8. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
[TBL] [Abstract][Full Text] [Related]
9. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
Jarosz-Chobot P
Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
[TBL] [Abstract][Full Text] [Related]
10. Rediscovery of insulin pump treatment of childhood type 1 diabetes.
Weinzimer SA; Doyle EA; Steffen AT; Sikes KA; Tamborlane WV
Minerva Med; 2004 Apr; 95(2):85-92. PubMed ID: 15272243
[TBL] [Abstract][Full Text] [Related]
11. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness.
Radermecker RP; Scheen AJ
Diabetes Metab Res Rev; 2004; 20(3):178-88. PubMed ID: 15133748
[TBL] [Abstract][Full Text] [Related]
12. Classification of distinct baseline insulin infusion patterns in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion therapy.
Holterhus PM; Odendahl R; Oesingmann S; Lepler R; Wagner V; Hiort O; Holl R; ;
Diabetes Care; 2007 Mar; 30(3):568-73. PubMed ID: 17327322
[TBL] [Abstract][Full Text] [Related]
13. Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII).
Shashaj B; Busetto E; Sulli N
Diabet Med; 2008 Sep; 25(9):1036-42. PubMed ID: 18937673
[TBL] [Abstract][Full Text] [Related]
14. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy.
Bruttomesso D; Costa S; Baritussio A
Diabetes Metab Res Rev; 2009 Feb; 25(2):99-111. PubMed ID: 19172576
[TBL] [Abstract][Full Text] [Related]
15. [Influence of the treatment with continuous subcutaneous insulin infusion (CSII) in the improvement of the quality of life of patients with type 1 diabetes mellitus].
Casas-Oñate ML; Montoya-Martínez D
Enferm Clin; 2010; 20(4):216-21. PubMed ID: 20561806
[TBL] [Abstract][Full Text] [Related]
16. [Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients].
Buczkowska EO; Dworzecki T; Wiedermann G; Malanowicz B; Szot D
Przegl Lek; 2005; 62(1):49-53. PubMed ID: 16053222
[TBL] [Abstract][Full Text] [Related]
17. Why pumps? Continuous subcutaneous insulin infusion for children and adolescents with type 1 diabetes.
Weintrob N; Shalitin S; Phillip M
Isr Med Assoc J; 2004 May; 6(5):271-5. PubMed ID: 15151365
[TBL] [Abstract][Full Text] [Related]
18. [Quality of life with intensive insulin therapy: a prospective comparison of insulin pen and pump].
Schiffers T
Psychother Psychosom Med Psychol; 1997 Jul; 47(7):249-54. PubMed ID: 9333836
[TBL] [Abstract][Full Text] [Related]
19. [Satisfaction and quality of life evaluation in patients with type 1 diabetes mellitus treated using continuous subcutaneous insulin infusion compared with multiple daily injections].
Lozano-Serrano M; García-Seco JA; García-Seco F; Lozano-Hernández MC; Seco-Segura ÁM; Moreno-Fernández J; Muñoz-Cazallas PA; Ferreiro-Vicario C; Sánchez-Covisa MA
Enferm Clin; 2013; 23(3):96-102. PubMed ID: 23755944
[TBL] [Abstract][Full Text] [Related]
20. Flexibility of rapid-acting insulin analogues in children and adolescents with diabetes mellitus.
Danne T
Clin Ther; 2007; 29 Suppl D():S145-52. PubMed ID: 18191066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]